Top 10 Companies in the Upconversion Nanoparticles Market (2025): Market Leaders Driving Innovation

Upconversion Nanoparticles Market Insights

Upconversion nanoparticles (UCNPs) are nanoscale phosphors that convert low‑energy near‑infrared photons into higher‑energy visible emission, enabling deep‑tissue bio‑imaging, anti‑counterfeiting inks, and solar‑cell enhancement. Because UCNPs can be excited with 980 nm NIR light, they provide low autofluorescence and high penetration depth, driving adoption in healthcare diagnostics. However, synthesis complexity and potential heating effects remain challenges. Furthermore, rising demand for security printing and the push for high‑efficiency upconversion layers in photovoltaics are expanding the market.

Market Overview

The UCNP market reached USD 620 million in 2025 and is projected to expand to USD 2,200 million by 2034, reflecting a compound annual growth rate of 15.1%. The primary drivers are the rapid uptake of UCNPs in biomedical imaging, the growing need for anti‑counterfeiting inks, and the push for high‑efficiency upconversion layers in next‑generation photovoltaics.

UCNPs uniquely convert near‑infrared photons to visible light, enabling deep‑tissue imaging with low background fluorescence, high‑purity color rendering in displays, and efficient light harvesting in solar cells.

1. Kojindo Chemical Lab

Headquarters: Tokyo, Japan

Key Offering: Lanthanide‑doped UCNPs with high quantum yield, core‑shell architectures for enhanced stability.

Kojindo’s proprietary hydrothermal synthesis delivers narrow size distributions and tunable emission wavelengths, positioning the company as a preferred supplier for research and early‑stage clinical probes.

Sustainability / Growth Initiatives: Investment in low‑energy synthesis, partnership with national research institutes to scale up production for commercial imaging systems.

• Collaboration with university labs to validate biocompatibility.
• Development of surface‑functionalized UCNPs for targeted drug delivery.
• Expansion of manufacturing capacity to meet rising demand in Asia‑Pacific.

2. Nanocs

Headquarters: San Jose, USA

Key Offering: Commercial catalog of UCNPs with customizable dopant profiles.

Nanocs supplies high‑quality UCNPs to pharmaceutical companies and imaging equipment manufacturers, leveraging its robust quality‑control system to ensure consistent optical performance.

Sustainability / Growth Initiatives: Focus on reducing rare‑earth consumption through optimized doping strategies.

• Implementation of closed‑loop synthesis to recycle unreacted precursors.
• Partnership with biotech firms to develop UCNP‑based biosensors.
• Exploration of eco‑friendly solvent systems.

3. Nanophase Technologies

Headquarters: Boston, USA

Key Offering: Core‑shell UCNPs optimized for photothermal therapy.

The company’s synthesis platform yields UCNPs with high surface area, enabling efficient heat conversion under NIR illumination, a critical attribute for targeted cancer treatment.

Sustainability / Growth Initiatives: Development of biodegradable coatings to improve in‑vivo clearance.

• Clinical collaboration with oncology centers for proof‑of‑concept studies.
• Integration of UCNPs into multifunctional theranostic platforms.
• Patent portfolio expansion around surface functionalization.

4. Mira Nanotech

Headquarters: San Diego, USA

Key Offering: Low‑temperature UCNP synthesis for flexible electronics.

Mira’s process allows integration of UCNPs onto polymer substrates, opening pathways for smart‑device displays and sensors that require minimal thermal stress.

Sustainability / Growth Initiatives: Focus on green chemistry and scalable continuous‑flow reactors.

• Partnership with consumer electronics manufacturers for prototype displays.
• Investigation of renewable‑energy‑driven reactors.
• Collaboration with materials scientists to develop flexible encapsulants.

5. UC Nanotech

Headquarters: Munich, Germany

Key Offering: Advanced surface‑engineered UCNPs for high‑resolution imaging.

UC Nanotech’s product line includes UCNPs with multi‑layer coatings that suppress non‑specific binding, making them attractive for multiplexed diagnostics.

Sustainability / Growth Initiatives: Commitment to reducing hazardous waste through process optimization.

• Collaboration with European regulatory bodies to streamline approval pathways.
• Investments in automated synthesis modules.
• Partnerships with imaging device manufacturers for co‑development.

6. NIR‑Medi

Headquarters: Seoul, South Korea

Key Offering: Biocompatible UCNPs tailored for clinical translation.

NIR‑Medi focuses on UCNPs that meet stringent safety standards, positioning itself as a supplier for regulatory‑approved imaging agents.

Sustainability / Growth Initiatives: Development of biodegradable surface ligands.

• Collaboration with national health agencies on clinical trials.
• Integration of UCNPs into point‑of‑care diagnostic kits.
• Research into multi‑modal imaging capabilities.

7. Lumicell

Headquarters: New York, USA

Key Offering: UCNP‑based security inks with high color purity.

Lumicell supplies inks that emit distinct visible signatures under NIR illumination, providing robust anti‑counterfeiting solutions for currency and high‑value documents.

Sustainability / Growth Initiatives: Exploration of low‑toxic pigment formulations.

• Partnership with printing companies for large‑scale deployment.
• Research into scalable inkjet printing of UCNPs.
• Collaboration with law‑enforcement agencies on authentication protocols.

8. Lumina Bio

Headquarters: San Francisco, USA

Key Offering: UCNPs engineered for deep‑tissue imaging in oncology.

Lumina Bio’s UCNPs are designed to maximize signal intensity while minimizing phototoxicity, supporting the development of next‑generation imaging probes for cancer diagnostics.

Sustainability / Growth Initiatives: Focus on reducing batch variability through automated synthesis.

• Collaboration with clinical research institutes for in‑vivo studies.
• Partnership with imaging equipment manufacturers for integrated platforms.
• Development of standardized QC protocols.

9. Horizon Nanomaterials

Headquarters: Austin, USA

Key Offering: High‑efficiency UCNPs for photovoltaic applications.

Horizon’s UCNPs are tailored for incorporation into tandem solar cells, enhancing light harvesting in the near‑infrared spectrum.

Sustainability / Growth Initiatives: Development of low‑temperature deposition techniques.

• Collaboration with renewable‑energy firms for prototype modules.
• Investments in scalable deposition equipment.
• Patents around thin‑film integration.

10. NanoPhotonics

Headquarters: Chicago, USA

Key Offering: Multifunctional UCNPs for sensing and imaging.

NanoPhotonics develops UCNPs that combine high quantum yield with surface chemistries enabling selective binding to biomarkers, supporting the creation of advanced diagnostic assays.

Sustainability / Growth Initiatives: Integration of green synthesis protocols.

• Partnership with diagnostic companies for assay development.
• Collaboration with academia on surface functionalization.
• Exploration of recyclable synthesis byproducts.

Outlook and Future Trends

The UCNP market is poised for sustained expansion as research advances in synthesis, surface engineering, and integration with emerging technologies. The convergence of UCNPs with microfluidic platforms, wearable sensors, and flexible photonic devices is expected to unlock new application avenues across healthcare, security, and energy sectors.

Key future drivers include:

• Development of low‑temperature, scalable reactors that reduce production costs.
• Enhanced surface chemistries enabling targeted delivery and multimodal imaging.
• Integration of UCNPs into next‑generation displays and lighting solutions.
• Regulatory alignment around safety and efficacy for clinical applications.
• Strategic partnerships between academia and industry to accelerate product pipelines.

These trends collectively position the UCNP market for continued growth, with a clear trajectory toward broader commercialization and deeper market penetration across multiple sectors.